About
Sunil Anklekar, Ph.D., is the Founder and Author of Pharma Fronts blogs, a radiopharmaceutical services company based in Concord, NC, bordering Charlotte. He is an experienced industry professional with three decades of experience in the chemical and radiopharmaceutical industry. He has worked for the last 16 years in the radiopharmaceutical sector. In his radiopharmaceutical career, he held leadership positions in the radiodiagnostics and radiotherapeutics areas and led teams for the manufacture of APIs and excipients. He was a technical lead on technology transfer projects for the qualification of APIs, excipients and Drug Products for the partner CDMOs from Japan, Europe, and US.
In the chemical industry, Dr. Anklekar held senior roles in process development and manufacturing. He served as a Plant Manager for one of the largest chemical CDMOs in the U.S.
Dr. Anklekar received his Ph.D. in synthetic organic chemistry from NC State University, Raleigh, NC, and was a post-doctoral research scientist at U. of Nebraska’s Epply Cancer Research Institute in Omaha, NE.
He offers consultation services to the financial community and the radiopharmaceutical industry, specializing in market analysis, manufacturing, and supply chains related to theranostic radioisotopes and drug products.
Dr. Anklekar is available for presentations on radiopharmaceutical topics to industry and academic audiences.
Professional Experience Snapshot
- Founder, Pharma Fronts (Jun 2025 – Present)
- Radiopharmaceutical Consultant (2022 – 2025)
- Head, API Manufacturing – Lantheus Medical Imaging, Billerica, MA (2009 – 2022)
GMP production of APIs for an MRI tracer and SPECT, PET, MRI and ultrasound tracers - Plant Manager – WeylChem, Elgin, SC (2005 – 2009)
Managed 100+tons/year manufacture of pharma, agro and specialty chemicals - Senior Process Development Chemist, WeylChem, Elgin, SC (1997 – 2005) Chemical Process development and scale-ups (1000-5000 gals)
- Postdoctoral Research Scientist – Eppley Cancer Research Institute, University of Nebraska Medical Center, Omaha, NE (1993 – 1997)
Synthesis of biomarkers for carcinogens and their quantification in in-vivo samples
Download Complimentary eReport
“Supply Chain Logistics For A PET Radiotracer Manufacture”
Supply chain for an 18F radioisotope based PET radiotracer manufacture is discussed in detail along with brief manufacturing descriptions provided for context. A critical report for supply chain, manufacturing, business and investing personnel to familiarize with the basics of supply chain for this category of high application, commercially critical PET diagnostic imaging agents.
Click the icon below to download the eReport.
Categories
Archives
Like to receive in-depth analysis on radiopharmaceuticals straight to your inbox?
(Emails are kept strictly confidential)